Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 41Melanoma 9Uterine Cervical Neoplasms 8Endometrial Neoplasms 7Mouth Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Vulvar Neoplasms 2Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphatic Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Rhabdomyosarcoma 1Recurrence 1Recurent Vulvar Carcinoma 1Prostatic Neoplasms 1Penile Neoplasms 1Pediatric Patients With Solid Tumors 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Node-positive Breast Cancer 1Neoplasms 1Neoplasm Micrometastasis 1

Interventions

Fluorouracil 26Radiotherapy 17Mitomycin 17Cisplatin 12Capecitabine 12pembrolizumab 10Cyclophosphamide 9Radiation 8Paclitaxel 8fludarabine 7Specimen Handling 7Nivolumab 7Carboplatin 7Magnetic Resonance Spectroscopy 6Cetuximab 6Biopsy 6Papillomavirus Vaccines 5Drug Therapy 5dehydroftorafur 4aldesleukin 4Vaccines 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Watchful Waiting 3Taxes 3Oxaliplatin 3Observation 3Light Coagulation 3Ipilimumab 3Interleukin-2 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anus Neoplasms × Sentinel Lymph Node Biopsy × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡